Speaker Biographies

Giada Acciaroli received her Ph.D. in Biomedical Engineering from the University of Padova (Italy) in 2018, and joined Dexcom just after her studies were completed. Giada is now part of the Data Science team at Dexcom, and her focus is data products development based on real-world data using statistical analysis and artificial intelligence.

Pratik leads the R&D strategy and roadmap for data science and Informatics Innovation at Medtronic Diabetes where he is responsible for technology pipeline and developing products that use data science and artificial intelligence to simplify diabetes management & achieve patient outcomes. This includes projects associated with algorithm development and analytics of continuous glucose monitoring (CGM), insulin pump information and other internal and external patient data from electronic medical records, wearable sensors and claims databases. Pratik has a Master of Science degree in Biomedical Engineering from the University of Southern California and over 15 years of experience in medical device industry. He joined Medtronic in 2010 and has been responsible for establishing and leading a data science team that is responsible for big data, predictive analytics and informatics efforts across the Diabetes Group. Pratik has played a central role in the development of the Sugar.IQ smart diabetes personal assistant mobile application. He also led the creation of decision support algorithms using statistical pattern recognition techniques for effective therapy management of type 2 patients.

Susan Alpert, PhD, MD is currently the principle of SFA Regulatory LLC, a one person firm focused on the strategies needed to place medical devices and other medical products into the global market. She was a Corporate Senior Vice President for Global Regulatory at Medtronic, Inc. and prior to that VP Regulatory Science at C.R. Bard, Inc. She previously worked at the US FDA where she held a variety of management positions in the Centers dealing with drugs, devices and radiological health, and foods. She was Director of the Office of Device Evaluation from 1993-1999. Susan is a microbiologist and pediatrician with a specialty in infectious diseases. She completed her undergraduate degree at Barnard College, Columbia University in New York City, holds a master’s degree and Ph.D. in Biomedical Sciences from New York University and a medical degree from the University of Miami (Florida). She is a member of several non- profit and for profit boards.

Robert's 30+ years' industry experience has been in the Internet of Things (IoT) and wearables / Industrial IoT (IIoT) / Connected Vehicle and Telecommunications markets. He has worked in the development of MicroElectroMechanical Systems (MEMS), Piezo-MEMS/sensors and semiconductor technologies. Robert's background includes: C-level, business development, strategic and brand marketing, engineering management, and senior scientist and engineering roles. He has been a entrepreneur previously, where he is the founder and former CEO of an energy harvesting IoT-based company, MicroGen Systems, Inc. Robert raised $8M between an angel round and a Series A round of investment plus an additional $4M in government grants over 6-years. The Company transferred the prototype piezo-MEMS vibration energy harvester (pVEH) process from the Cornell Nanoscale Science and Technology Facility in Ithaca, NY to 200 mm diameter high volume manufacturing at X-FAB in Itzehoe, Germany with >85% overall manufacturing product yield including wafer-level packaging. The team developed the first fully integrated tire-pressure monitoring system (TPMS) module powered by its pVEH product for Class 8 long-haul commercial truck tires with Melexis N.V. from Belgium and the largest tire company in the world (proprietary, not Lego! Google it!). These were successfully tested in truck tires over 4-years on tire drum testers up to 75 mph (120 kph), the modules reached 80 °C (could handle up to 125 °C) for 3,100+ miles (5,000 km) without issue. The company's Intelligence Tire System (ITS) module product was pre-announced at the Automotive Sensors Expo in Detroit in 2016. The MicroGen team also released several products to the IIoT market, and ultimately the company was sold in July 2017. The company was recognized as a Top 25 Silicon Valley Company (MicroGen was located in Rochester, NY), an EE Times' Silicon 60 inductee for 4-years running, was runner up for Startup Company of the Year by SEMI MSIG, won Engineering Team of the Year by Sensors Expo, and more. Robert is also considered to be in the Top 12 Movers and Shakers in MEMS by EE Times. He holds a Ph.D. in Materials Science, a multidisciplinary degree, where he focused on Electrical Engineering and Physics. He has been an invited speaker on IoT, EH and MEMS/sensors all over the world over 30X, where six have been Keynotes. Robert holds 25+ issued US and international patents.

Dr. Leonardo Angelone is the Deputy Director for the Office of Translational Initiatives and Program Innovations at the National Institutes on Drug Abuse (NIDA). He serves as the program lead of the “RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19)” program, as part of the NIH Rapid Acceleration of Diagnostics (RADX) initiative, launched to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. He also serves as Program Lead of the new Trans-NIH Blueprint MedTech Program and as Program Officer of the NIDA small business innovation research (SBIR) and small business technology transfer (STTR) programs, with emphasis on Medical Devices and Digital Therapeutics. Dr. Angelone provides leadership for the vigorous pursuit of excellence in research translation and utilization of innovative programs to speed the application of research discoveries in the prevention, monitoring, diagnosis, and treatment of substance use disorders. Dr. Angelone has completed a Laurea (Doctor) in Electrical Engineering from University of Rome, Sapienza, a PhD in Biomedical Engineering from Tufts University (Medford, MA), and a Research Fellowship from the Department of Radiology, Harvard Medical School.

Dr. Gregory W. Auner is a Strauss/TEAMS (Technology and Engineering Applications in Medicine and Surgery) Endowed Chair and Professor in the Department of Surgery and Biomedical Engineering. He also has appointments in the Department of Electrical and Computer Engineering the Department of Physics at Wayne State University in Detroit, MI. He is the Director of Research for the Detroit Institute of Ophthalmology at Henry Ford Health systems Department of Ophthalmology and Scientific Member Developmental Therapeutics Program- Karmanos Cancer Institute. He is the founder and director of the Smart Sensors and Integrated Microsystems (SSIM) program at WSU which encompasses 8 centrally located laboratories over 150 participating faculty, graduate students, staff scientists/engineers, and undergraduate researchers. He has developed an array of instruments, sensors and microsystems, software and communication systems for federal institutions and industry. Approximately 90% of his research involves the research and development of microsystems, nanosystems, intelligent deep learning systems and BioMEMS systems. He has performed extensive research for the Department of Defense, The National Institute of Health, the National Science Foundations, the Defense Threat Reduction Agency, and the Biomedical Advance Research and Development Authority in the areas of water borne chemical and bacteria sensing , Radiation dosimetry in human exposure, airborne pathogen detection, signal analysis, and encrypted communications. He has been the Principle Investigator on more than $40 M in peer reviewed funding grants and contracts. He has over 40 patents (issued and pending) in the last several years for bio implants, chemical, biomedical, and environmental sensing with Raman spectroscopy, and microsystems lab on a chip development. He has over 300 peer reviewed publications and over 4000 citations. He has received a number of awards including Crain’s Healthcare Hero Award 2018, the Strauss Endowed Chair, Induction to the 2007-2008 Class of Leaders & Innovators, WSU Alumni Faculty Service Award, RARE Foundation’s Everyday Hero Award, the Award for Outstanding Contribution to the Advancement of Knowledge- American Society for Reproductive Medicine to name a few. Dr. Auner was appointed to the National Academies Board on Manufacturing Design and Engineering in 2004. He is also the Co-Founder and Chief Science & Technical Officer at Seraph Biosciences and Visca, LLC, - Wayne State University SSIM program spin-off companies.

Co-Founder and CEO of Osso VR, Dr. Justin Barad, is a board-eligible orthopaedic surgeon with a bioengineering degree from UC Berkeley, and an MD from UCLA, where he graduated first in his class. He completed his residency at UCLA and his fellowship in pediatric orthopaedics at Harvard and Boston Children’s Hospital. Justin is currently practicing at the Orthopaedic Institute for Children. Aside from medicine, Justin, who has been a lifelong coder and has a game credit with Activision, originally wanted to be a game developer. When a personal family health incident introduced him to the world of healthcare, he decided to find a way to combine his passions and use his technology background to solve medical problems. During his residency, he identified what could be one of the most pressing medical challenges of this century: how we are training our surgeons. With a strong interest in gaming and a first-hand understanding of the challenges facing residents and experienced doctors, he co-founded Osso VR with a mission to improve patient safety and democratize access to modern surgical techniques.

Dr. Jon Bloom is a board-certified physician and entrepreneur with over 15 years of experience in technology development, patient monitoring, biomedical research, and health care delivery. He is the chief executive officer of Podimetrics, a virtual care management company dedicated to preventing diabetic amputations, one of the most debilitating and costly complications of diabetes. Dr. Bloom previously served as a Clinical Assistant Professor and staff anesthesiologist at The University of Pittsburgh Medical Center. He also served as the Director of Global Medical Affairs for Covidien's Respiratory and Monitoring Solutions division in Boulder, Colorado. He is a diplomate of the American Board of Anesthesiology and has co-authored more than 20 peer-reviewed publications with a focus on health care economics and perioperative complications.

Debbie Chen has a B.S. in Bioengineering from UCSD and a Ph.D. from Tufts University. For her thesis, she developed an early diagnostic tool based in near-infrared spectroscopy to diagnose early peripheral neuropathy. She did a Postdoc at UCSD Medical School in Pathology specializing in diabetic neuropathy and a second Postdoc at Scripps Institute of Oceanography, developing a 3D in-vitro plankton microscope. She was an Imaging Scientist at Sanford Burnham Prebys (SBP), managing the High-Content Screening Microscopy Core for Drug Discovery. In July 2018, she decided to make the plunge into entrepreneurship, combining her optical device expertise and her passions as an amateur Muay Thai fighter. She realized that there is a need for a personalized, continuous hydration monitor for athletes as well as in hospitals and believes that hydration monitoring should be the standard of care in sports and healthcare. Hydrostasis is a B2B initially focusing on collegiate teams to provide a continuous hydration sensor wearable and team analytics platform. Patented sensor design and algorithms combine measures of blood flow, skin tone, fat content, as well as hydration into a personalized hydration index. Machine learning algorithms provide an optimal hydration range for each individual and notifies coaches and athletes before they exit their optimal range, thereby avoiding symptoms of dehydration and overhydration. After customer validation and traction in the sports sector, Hydrostasis aims to enter into the Healthcare system in 2021.

Epigenetics, tissue engineering, immunology, pharmacology, biomedical patent law, semiconductor technology. Those terms briefly capture the path that Erik has taken to get to this moment. With a passion for life science research and innovation, Erik has developed a broad perspective on how advanced technology can improve the state of healthcare. As a strategic partnership manager for life science technology at imec, Erik fosters innovation by connecting innovative life science companies to imec’s top-notch researchers and state-of-the-art infrastructure. For this event, Erik will present on recent developments in integrated photonic and acoustic technologies as they relate to the future of ultrasonography and photo-acoustic imaging.

Darrel Drinan, MS is Co-Founder & CEO of RayBalance. RayBalance is developing a novel hearing loss restoration and preservation system based upon Photobiomodulation Therapy (PBMT) to mitigate impaired (injured/damaged) inner ear hair and supporting cells. Prior to founding RayBalance, Darrel was the Founder / CEO of a digital health incubator, PhiloMetron located in San Diego. Several internally generated ventures successfully graduated from Philo’s incubator – Corventis and BioRibbon Health. Philo’s team successfully guided the development and commercialization of dozens of other external ventures over the last two decades. Prior to founding PhiloMetron, Mr. Drinan was the Director of New Product Management for Braun ThermoScan, a $2B subsidiary of the Gillette Company. He led the development and commercialization of new consumer medical products for Braun, including research in wireless, non-invasive, medical sensing applications markets. He led multi-disciplined development teams located in several countries. Mr. Drinan holds a BS in Production/Operations Management and an MS in Business.

Dr Robert Fearn, MD, is currently CMO and Product Architect at 11 Health, a digital medicine company making continuous monitoring devices for patients with ostomy and chronic digestive diseases. He is also an assistant clinical professor at UCI. As a board-certified gastroenterologist, he specialized in the management of inflammatory bowel disease and clinical nutrition including intestinal failure and initially practiced in London and Cambridge, UK, where he also led multiple digital transformation initiatives. Having seen so many of his patients impacted negatively by the lack of tools to monitor and manage their condition outside of the hospital he joined 11 Health at an early stage to shape the clinical product development program. A physician, innovator, and advocate for patient-centered care, his vision is to create products that solve real and definable clinical and social pain points for patients and their medical teams by providing patients with actionable data and supporting them to drive their own improved outcomes. Working with biomedical engineers, software developers, and a team of patients and clinicians, he has overseen multiple development cycles, supporting clinical studies and regulatory approval to bring innovative remote monitoring products to market in the USA and globally.

Stacy has more than 24 years of diverse business experience translating innovative science and technology into transformative commercial solutions for patients and consumers. She has held a range of leadership positions in the healthcare, biotech, life sciences and consumer health sectors as a business development executive, venture capital investor, business and innovation strategist and transactional attorney. Stacy is Head of Johnson & Johnson Innovation, West North America, Australia & New Zealand, located at the Innovation Center in South San Francisco, California. In this role, she lead the Johnson & Johnson Innovation team to build, advance, and manage a portfolio of co-investments and collaborations spanning the pharmaceutical, consumer health and medical device sectors. Stacy is also responsible for expanding and nurturing the external networks within the innovation community, including academia, venture capital, entrepreneurs and other governmental and private organizations.

Elaine Gee, PhD is the Principal Data Scientist at Mirvie. Mirvie’s mission is to bring pregnancy out of the dark for a more confident path to a healthy pregnancy with a simple non-invasive blood test. Dr. Gee applies machine learning and bioinformatics pipeline development best practices to Mirvie’s cell-free RNA technology to develop a simple blood test for the early detection of pregnancy complications, such as preterm birth, preeclampsia, and gestational diabetes. Prior to joining the Mirvie Informatics team, Elaine developed machine learning algorithms for real-time wearable sensors at Medtronic to support individualized diabetes management as a Senior Principal Algorithm Development Engineer in the Diabetes Group. At Medtronic, Dr. Gee was awarded the 2020 Technical Contributor of the Year for her algorithm work on continuous glucose monitors. Dr. Gee’s prior experience also includes scaling NGS pipelines for germline, somatic, and infectious disease assays as the Director of Bioinformatics at ARUP Laboratories. She currently volunteers as the Informatics Subdivision representative on the Clinical Practice Committee for the Association for Molecular Pathology (AMP) and has previously served on the organizing committee for AMP’s 2019 Global Congress on Molecular Pathology. Elaine is also the founder and principal consultant of BigHead Analytics Group (BHA), where she consults on bioinformatics and machine learning projects. Elaine has authored 9 patents and patent applications. She obtained her PhD in Biophysics from Harvard University and a BS in Physics with Honors from the California Institute of Technology.

Dr. Ilana Goldberg joined the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in 2019 as an AAAS Science & Technology Policy Fellow. She is currently a Program Director and has oversight of the small business portfolio. Dr. Goldberg earned her B.S. degree from Brandeis University in Chemistry and Biochemistry, where she gained expertise in protein crystallography. She earned her PhD degree from Georgetown University in solid state and analytical chemistry where she focused on the crystal growth of secondary explosives. In 2005, she was awarded a Fulbright Fellowship to study crystal engineering, polymorphism, and co-crystallization of small molecules at Ben Gurion University in Be’er Sheva, Israel. Prior to her current position she was a project manager in Global Medical Excellence for AstraZeneca. Dr. Goldberg spent five years as senior scientist and project manager at the Johns Hopkins University Applied Physics Laboratory where were managed multidisciplinary research projects for homeland security. Before that, she was Postdoctoral Research Fellow at the Transportation Security Laboratory in Atlantic City, New Jersey, where she focused on the development of thermal analysis methods for energetic materials as well as the advancement of explosive detection technologies.

Mary is an accomplished leader in the Medical Device Reimbursement and Health Economics sector with over 30 years of experience developing and executing strategic reimbursement plans for medical technologies from regulatory approval through commercialization. She has a comprehensive understanding of the U.S. healthcare environment with demonstrated success supporting new medical technologies across various clinical applications. In addition, she has extensive experience developing and managing reimbursement and patient access strategies to secure coverage and payment from government and third-party payers. Mary has also worked closely with institutional investors conducting due diligence to evaluate various private equity medical technology investment opportunities.

Seth Hara is a Senior Engineer within the Division of Engineering at Mayo Clinic. He leads the Microfabrication Laboratory where electrodes, sensors, and other microdevices are developed in collaboration with researchers and clinicians throughout the Mayo Clinic enterprise. Seth earned his Bachelor of Science in Engineering from Swarthmore College and completed his Ph.D. in Biomedical Engineering with the Biomedical Microsystems Laboratory at the University of Southern California.

Umer Hassan is an Associate Professor in the Department of Electrical and Computer Engineering and Core Faculty Global Health Institute at Rutgers University. Before joining Rutgers, he worked as a Research Scientist in the Department of Bioengineering at University of Illinois Urbana-Champaign (UIUC) with a Research Affiliate appointment at Carle Foundation Hospital, Urbana. Dr. Hassan’s research efforts have been focused on developing bioengineering solutions for global-health applications including point-of-care (PoC) biosensors development for disease diagnosis. Dr. Hassan has received Brandt Early Career Investigator Award in Precision Medicine (2017), BMES Career Development Award (2017), Baxter Young Investigator Award (2016, 17), Emerging Engineer Award (2015), Cozad New Venture Competition Award (2014), NSF I-Corps Fellowship (2014) and Our Common Future Fellowship (2010). In 2014, Umer cofounded a startup, Prenosis, Inc. that is working on commercializing his developed biosensors.

Lisa Hedges is an Associate Principal Analyst at Gartner Digital Markets, where she has covered healthcare technology and market trends for the past four years. She has recently conducted original research and reported on such topics as physician burnout, telemedicine adoption, medical marketing, and the patients' perspective on medical wearable devices. She is inspired by the incredible work healthcare researchers and technology developers are doing to improve patients’ lives and make running a practice easier. Lisa studied English at Mississippi College and her research has been published in Healthcare IT News, Healthcare Innovation, the Chicago Sun-Times, and Digital Journal.

Peter Henstock has worked to transform Pfizer using AI and Machine Learning. He is the former Machine Learning and AI Lead based in Massachusetts. He holds a PhD in Artificial Intelligence from Purdue University and 7 Master’s degrees. Before joining Pfizer, Peter worked at MIT Lincoln Laboratory in image processing and computational linguistics. He also teaches graduate-level Machine Learning & Data Mining, and Software Engineering at Harvard University.

Director of Enterprise Risk Management at Baxter Healthcare globally responsible for reviewing Security Policies, Controls and Cyber incident response planning. Assist in Investigations after breaches or incidents. Develop process/means that help to collect cyber threat intelligence, track emerging vulnerabilities in software, strategize resolution approaches, communication to regulatory bodies and customers. Provides strategic and tactical security guidance for programs, projects, and data management and use agreements that may involve security controls, including evaluation of the architecture, hardware, software and technical controls. Formerly the North America Cybersecurity Program Manager at a Notified Body TÜV SÜD with 20 plus years of regulatory, testing and verification & validation experience. Knowledgeable in international regulations, cybersecurity, human factors, Notified Body, FDA, electrical and EMC testing, biocompatibility, and risk mitigation. Participated in the UL/VA CRADA for cybersecurity, FDA pre-cert workshops, Health Trust Cybersecurity Summit and Mayo Clinic’s Clinical Information Security validated external security firms. Strategic advisor for an AdvaMed start-up of the year and an Angel investor. Member of the IEEE P2933 committee – Clinical IoT Data and Device Interoperability with TIPPSS (Trust, Identity, Privacy, Protection, Safety, Security) Working Group. Council member for the AI at the Point of Care Team (AI@POC) is designed for Physicians and Healthcare System Members seeking to leverage Augmented Intelligence to improve patient care, clinical workflows, and system operations. Certified ISO 27001 Information Security Management Systems Lead Internal Auditor and certified Threat and Risk Management with NIST 800-53 and MITRE ATT&CK frameworks.

Jennifer Joe, MD, is the Chief Medical Officer of Carna.Health, a digital platform bringing the first home-use, CLIA-waved, FDA-cleared capillary blood fingerstick multiplex of the most common clinical electrolyte and metabolite blood tests to market, reporting results to patients/clinicians in just minutes, enabling the transformation of care from hospital to home. Prior to this, Dr. Joe founded and was CEO of Medstro, a software a service product that is widely used for hospital organizations like the NEJM Resident’s 360 and the American Medical Association, which she guided through acquisition and integration in 2019. Dr. Joe also founded and was CEO of a media organization, MedTech Boston, which she also guided through acquisition. Dr. Joe has been supporting healthcare innovation, with specific expertise in digital health and medtech, with large and small companies, including Boston Scientific, Philips, Google, and others, since 2013. Additionally, Dr. Joe is a practicing emergency room, urgent care, and hospitalist physician at 3 Boston hospitals where she also oversees students, residents, and fellows training.

Sari Kaganoff is the General Manager of Consulting at Rock Health, a venture capital fund and advisory services business focused on digital health. Our advisory business supports major corporations on digital health strategy, helping our clients stay in the know and compete effectively in the evolving digital health landscape. Sari joined Rock Health from McKinsey & Company, where she spent seven years in the Tel Aviv and New Jersey offices. At McKinsey, Sari co-led McKinsey’s Health Tech Network, a network of startups innovating in healthcare. She also co-led the Patient Experience Domain, working with life science and healthcare companies to improve patient experience using digital, data, and analytics. She worked with many global life science and healthcare companies on their digital health initiatives. While at McKinsey, Sari published several articles on digital health and patient adherence, as well as co-authoring an e-book, Pharma3D, with Google. Prior to her time at McKinsey & Company, Sari received an MBA with honors from University of Chicago Booth School of Business, majoring in Entrepreneurship and General Management. Prior to receiving her MBA she worked at a healthcare startup and at a fintech startup. She received her undergraduate degree in Technology and Communications from Michlalah Jerusalem College. Sari lives with her family in Puerto Rico.

Jaydeo brings over two decades of leadership experience with entrepreneurial mindset in building & scaling innovation businesses. He has a track record of leading several concept-to-launch innovation businesses at GE, Philips, Best Buy Health, and an automotive startup where he started his career journey. He has successfully built & operated health technology & service businesses at the intersection of Med Device/IoT, Virtual Care, and Retail/Consumer Health. He is passionate about creating empathy-driven experiences that transcend patient-consumer journeys. Under Jaydeo’s leadership, businesses have been transformed into growth engines with strong revenue acceleration, margin expansion, & shareholder value creation. Jaydeo is currently the Vice President of Strategy & Offering at Best Buy Health. He is responsible for spearheading Best Buy’s efforts in Virtual Care through business strategy, offerings (product), & partnerships in Provider, Payer, & Senior Living markets. In prior leadership role at Philips, he led portfolio strategy transformation across Connected Care business. Prior to that, he built & scaled a Digital Health venture at Philips, focused on Remote Patient Monitoring through medical-grade biosensors/wearables, cloud platform with clinical workflows, & analytics and seamless service. He has also established & scaled several businesses at GE including an innovation venture focused on IoT sensors and predictive analytics. Jaydeo is a frequent speaker & thought leader at Digital Health events and a co-author of Springer textbook on “Healthcare Information Technology for Cardiovascular Medicine.” He also serves on the Board for Directors at MassMEDIC and CTA Health Division organizations.

Farah Laiwalla, MD/PhD, is an Assistant Professor of Engineering (Research) at Brown University in Rhode Island. Dr. Laiwalla has 15+ years of experience in integrated circuit design and works on the development of chronic implants for neural prostheses, with a focus on integrated circuit development for smart, dynamic sensing and actuation of neural pathways in the brain. Recent research in her group has been directed toward the design of neurograins, which are sub-millimeter electronic implants integrating wireless energy harvesting, neural sensing, cortical microstimulation, and high speed (10 Mbps) wireless communication. Neurograins are designed for distributed implantation, with capabilities for reconfigurable, networked, bidirectional telecommunications.

Geert studied Electrical Engineering at the University of Twente. He obtained a Ph.D. from the same university on lab-on-a-chip technology and algorithms. Currently, he is program manager for the Health Research track, from this position he gives direction to develop technical building blocks for implants improving the life of chronic patients. The research of Geert has resulted into over 50 patent applications and over 60 publications, books and book chapters.

Kunal Mankodiya, PhD is the Director of Wearable Biosensing Lab and is an associate professor in the Dept. of Electrical, Computer, and Biomedical Engineering, University of Rhode Island, RI, USA since 2014. He is a co-founder at EchoWear, a startup aiming to offer digital health services and wearable tech to people with chronic conditions. He is a recipient of NSF CAREER (2016) Award enabling research on “Internet of e-textile wearables for telemedicine". In 2018, he received TechConnect Defense Innovation Award for his work on “Smart Textile Trouser". He was recognized as the “Innovator-of-the-year” by Future Textiles Awards, Frankfurt, Germany in 2017. Mankodiya was also selected among “40 under 40” by Providence Business News in 2017. His design of a smart-textile ECG system earned him the 2010 SYSTEX Award, University of Ghent, Belgium. He is an associate editor of the IEEE Internet of Things Journal and the Frontiers Journal of Wearable Electronics. He runs various outreach activities including HealthHacks, IOT Sunday, Paper Circuits, and BME Spark to promote STEAM among K-12 and undergraduate students. He pursued his postdoctoral research at Intel Science & Technology Center (ISTC) and Carnegie Mellon University (CMU), Pittsburgh, PA, USA. He received his Ph.D. degree from the University of Luebeck, Germany. He holds MS (University of Luebeck, Germany) and BE (Saurashtra University, India) degrees in Biomedical Engineering.

Manasi Marathe is the Senior Director of Strategy & Corporate Development at Tandem Diabetes Care. She is responsible for supporting the definition and development of the company’s long-term strategic direction, and ensuring its effective communication to internal and external audiences. Prior to joining Tandem, Manasi held various positions in strategy, corporate development, business development, and product management, in the MedTech and Technology industries, at Philips Healthcare, Qualcomm, and Medtronic. She holds Bachelors and Masters degrees in Computer Science and an MBA from The Wharton School, University of Pennsylvania. Manasi lives in San Diego with her husband and their daughter. In her spare time she enjoys the outdoors and traveling with her family.

My journey has evolved from systems biology to practicing medicine, to co-leading the digital transformation and virtual care initiatives at a large IDN, to healthcare data interoperability, to machine learning analytics, to investing in healthcare technology (diagnostic, therapeutic, value-based care delivery incorporating virtual care and virtual clinical trials). He is board member and/or advisor to a diverse portfolio of AI and Health IT companies.

Arben Merkoçi is currently ICREA Professor and Director of the Nanobioelectronics & Biosensors Group at Institut Català de Nanociencia i Nanotecnologia (ICN2), part of Barcelona Institute of Science and Technology (BIST). His research is focused on the design and application of cutting-edge nanotechnology and nanoscience-based cost/efficient biosensors. The paper/plastic-based nanobiosensors involve integration of biological molecules (DNA, antibodies, cells, and enzymes) and other (bio)receptors with micro- and nanostructures/motors and applied in diagnostics, environmental monitoring, or safety and security. He has published around 310 peer review research papers (H index: 70 WOS; 87 GS), supervised 30 PhD students and has been invited to give plenary lectures and keynote speeches in around 200 occasions in various countries. Prof. Merkoçi is Co-Editor-in-Chief of Biosensors and Bioelectronics and member of Editorial Board of other journals. He is co-founder of two spin-off companies, PaperDrop dedicated to nanodiagnostics, and GraphenicaLab to electronic printing.

Data Scientist with 12+ years’ experience in Advanced Analytics, Statistical Modeling, Descriptive & Inferential Statistics, Forecasting & Time Series Analysis, Regressions, Decision Trees, Random Forests, Text Mining, Neural Networks, Clustering. Educational background is Master of Science degree with specialization in Industrial and Systems Engineering and minor in Business Intelligence and Data Warehousing from University of Southern California, Los Angeles. After graduation, I’ve worked with Fortune 100 and FTSE 100 companies focusing on B2B and B2C.

John is the Director of the Invention Accelerator Program (IAP) at Fogarty Innovation, a non-profit hub for medical technology companies. The IAP works with physicians, nurses, and health care providers to help develop their ideas into innovations.Past experience included several efforts through The Foundry medical device incubator, including co-founding and serving as vice president of research and development at Twelve. Prior to the Foundry, John worked in R&D for Acclarent, Coapt, and several companies within consumer product design. He is an inventor on over 100 patents.John holds a BA from Duke University, a BS in Mechanical Engineering from North Carolina State University, and a MS in Mechanical Engineering from Stanford University.

As Head of JLABS, San Diego, Nick is responsible for setting the strategy and overseeing all operational activities of JLABS in San Diego. Nick joined Johnson & Johnson Innovation from the West North America Regional Team where he supported both Discovery, Product Development and Supply for Janssen, and Johnson & Johnson’s Medical Device businesses. Nick originally joined Johnson & Johnson Innovation in a New Ventures role supporting Johnson & Johnson’s Medical Device businesses, which included time on JJDC’s subcommittee for early-stage investments. During this tenure, he successfully completed numerous R&D Collaborations and Equity Investments. Prior to Johnson & Johnson, Nick served as PARC's Director of Global Healthcare Innovation and as the Xerox Innovation Group’s Healthcare Program Manager. Nick’s passion for helping entrepreneurs stems from his own start-up experience, which includes founding companies in orthopedics, cardiology, and radiation oncology. He was the Founder of Akros Medical (acquired by Johnson & Johnson), CEO of Tarsus Medical (acquired by Integra Life Sciences), Founder and CEO of Acumen Medical (acquired by Medtronic), and Founder of Siris Medical. Siris developed the first 510(k)-cleared AI/ML-based clinical decision support software for external-beam radiation treatment planning. Nick earned his PhD in Electrical Engineering from Stanford University where he was the John B. Simpson Biomedical Innovation Technology Fellow in the inaugural year of Stanford's Biodesign Fellowship Program. He also received his AB in Engineering Sciences from Dartmouth College and a BE from Dartmouth’s Thayer School.

7 years of IoT industry experience with a focus on new business development, product management, market research. Specialized in tracking market developments, identifying growth opportunities, strategic positioning and communicating value proposition of high value segments. Research enables her to empathize and recognize users’ desires to design enhanced user-focused technology. She enjoys collaborating with healthcare firms, hospitals and health centers and believes connected healthcare and personalized medicine is the future.

Vivian Neilley is the Lead Interoperability Solutions Engineer for Google Cloud. In this role, Vivian is responsible for designing and publishing solutions for the various industry use cases as well as aligning with customers to ensure successful Google Cloud journeys. Her focus in the position is around enabling customers to ingest, harmonize, and derive insights from data to meet business needs and prepare for scale in the new age of AI. She also leads the healthcare standards group at Alphabet aligning various product areas and promoting the use of healthcare standards.

Dr. Alisa Niksch is a pediatric cardiologist and electrophysiologist and currently serves as Senior Director of Medical Affairs at Owlet Baby Care, Inc. She has lent her experience to the digital health, medical device, and remote patient monitoring fields since starting her practice at Tufts Medical Center in 2010. Dr. Niksch was Chief Medical Officer of Genetesis, Inc., a company which created a novel cloud-connected and AI-powered cardiac diagnostics and imaging platform, where she led pivotal clinical trials and managed medical affairs initiatives. She has been an advisor and researcher for multiple healthcare companies like AliveCor, Cohere Health, Ometri, PraxSim VR, Medaica, Mindchild Medical, Zephyr Technologies, and Sproutling. She continues to be a startup mentor with programs at Northeastern University and MassChallenge HealthTech. She has authored a book chapter and articles in peer-reviewed journals on digital health and wearable technologies, and has spoken on the applications of AI in medicine and the role and design of wearable technologies in clinical practice. She is a graduate of The University of Virginia School of Medicine, and completed her cardiology and electrophysiology fellowship training at Morgan Stanley Children’s Hospital at Columbia University Medical Center and Stanford/UCSF Medical Centers, respectively.

Jonathan Norris is a Managing Director at HSBC Innovation. Previously, he was Managing Director of Venture Capital Relationships for Silicon Valley Bank, where he oversaw business development efforts for banking and lending opportunities as well as spearheading strategic relationships with many life science and healthcare venture capital firms. He also helped SVB Capital through sourcing and advising on limited partnership allocations. In addition, he speaks at major investor and industry conferences and authors widely cited analyses of healthcare venture capital trends. Norris has more than sixteen years of banking experience working with healthcare companies and venture capital firms. Norris earned a bachelor's degree in business administration from the University of California, Riverside and a juris doctorate from Santa Clara University.

Sean O’Brien is the Director of Health at Home Technologies at Stanley Healthcare, a Division of Stanley Black & Decker. He is responsible for all product, marketing, sales and operations for Health at Home. O’Brien was the former Vice President and General Manager of Honeywell Global Retail. O’Brien was responsible for developing and executing strategic growth plans for Honeywell retail brands including The Original Muck Boot Company, XTRATUF Boots, Oliver Work Boots, Kings and Howard Leight by Honeywell. He developed a track record of business transformation and sustainable results through strategic marketing, new product development, portfolio management, and operational excellence. O'Brien has more than 28 years of experience in B2C/B2B, with deep knowledge in the consumer products industry. Prior to Honeywell, O'Brien served as the Senior Director of Product Merchandising for Converse brands, a Nike company. His experience includes senior product marketing roles with Wilson Sporting Goods and New Balance.

Kalyan Pamarthy leads product management for healthcare data interoperability and AI on Google Cloud’s Healthcare & Life Sciences team. In his role, Kalyan manages the product portfolio for Google Cloud Healthcare and AI products and works with health systems, health plans, and technology companies to manage healthcare data securely in the cloud and develop interoperable healthcare AI applications at scale. Kalyan has over 15 years of experience in building healthcare and AI applications.

Since joining Lilly in 1999, Jim Parshall has held various technical and leadership positions in manufacturing, IT, and product development. In each of his roles, he has championed disruptive innovation to create significant business impact within the 145-year-old pharmaceutical company. Assuming his current role in 2019, Jim is responsible for identifying, evaluating, and executing external connected health opportunities to support Lilly's key therapeutic areas. Prior to his external innovation role, Jim was Lilly’s Director of Software Device Solutions, where he recruited and led a talented and energized team that was passionate about leveraging connected health to improve patient outcomes. Jim has enjoyed serving on boards for small businesses and industry associations and is currently the chair of the HIMSS Personal Connected Health Alliance Advisory Board. His book, Applying S88: Batch Control from a User’s Perspective, a guide on implementing modular software for manufacturing, continues to influence projects, operations, and thinking worldwide. Jim earned a B.S. in electrical engineering from Kettering University and an M.S. in electrical engineering from Purdue University. Before joining Lilly, Jim worked as a lead process and automation engineer at Ben & Jerry’s Homemade, where he learned that eating one's own mistakes could actually taste good.

Dr. Polsky earned his PhD at New Mexico State University under Joseph Wang developing nanoparticle labels for ultrasensitive electrochemical detection of DNA and proteins. He spent one year as a post-doctoral fellow at the Hebrew University of Jerusalem under Itamar Willner before joining Sandia National Laboratories as a staff scientist in 2006. At Sandia he has worked on development of electrochemical biosensors, autonomous miniaturized field deployable devices, surface chemistries for functionalization of high-density electrode arrays and fabrication of three-dimensional electrodes for battery and sensing applications. His current activities are focused on the development of a wearable microneedle sensor device and exploring how dermal interstitial fluid can be used as a novel bio-fluid to clinically diagnose a range of health states as an alternative to blood sampling.

Mary-Suzanne has built a twenty+ year career around improving building performance and business efficiency while working for companies that are dedicated to helping the world run smarter, smoother and safer. In her current role, she serves as the vice president for vertical markets and advanced solutions at Johnson Controls as part of the Building Solutions North America (BSNA) division. She leads a team of global experts who provide customers with a complete portfolio of operating solutions comprised of data platforms, digital solutions, applications and building systems that harness data from inside and outside structures to deliver financial outcomes and enhance building performance, safety, and comfort. Mary-Suzanne’s experience spans leading business activities specialized in energy, construction, and smart technology for the higher education, K-12, state and local government, healthcare, hospitality, and commercial buildings industries. Mary-Suzanne holds a bachelor’s degree in economics and international relations from The University of Virginia.

Matt Quinn is the Science Director for the Army’s Telemedicine & Advanced Technology Research Center (TATRC) and leads efforts by TATRC’s research & development teams to forge the future by fusing data, humans, and machines into solutions that optimize Warfighter performance and casualty care. Matt has over 20 years of experience in health technology across federal agencies including the Agency for Healthcare Research and Quality (AHRQ), the National Institute of Standards and Technology (NIST), the Federal Communications Commission (FCC), the Heath Resources and Services Administration (HRSA), the U.S. Army as an Engineer Officer and in the private sector at Intel Corporation, where he was Managing Director of Healthcare and Life Sciences and at Teradata, where he was Healthcare Industry Manager. Mr. Quinn has been deeply involved in advancing health innovation and, while Director of Healthcare Initiatives at the FCC co-authored the FDASIA report for Congress on the regulatory framework for health technology and at AHRQ and NIST co-authored key guidance which led to “safety-enhanced design” EHR certification requirements. Matt has testified before the Senate and the House of Representatives, been recognized multiple times with the FedHealthIT100 award for driving change and advancement in the Federal Health IT ecosystem, received the HHS Distinguished Service Award, the highest honor granted by the department, the Army Meritorious Civilian Service Medal for his work in launching the National Emergency Tele-Critical Care Network (NETCCN) and the first ever National Health IT Collaborative for the Underserved "Champion of Diversity" award. He earned an engineering degree from the United States Military Academy at West Point and an MBA from Colorado State University.

Ernesto Ramirez, PhD, is a Senior Manager in the Research, Analytics, and Learning team at Evidation. His focus is on designing and delivering innovative clinical and market research opportunities and programs for our 4 million Evidation members. Ernesto has led and been an active member in multiple research initiatives at Evidation, including our recent BARDA-supported research exploring the role of wearable sensor data in better understanding, classifying, and predicting infectious diseases such as influenza and COVID-19. Recently, Ernesto has been contributing to the Digital Health Measurement Collaborative Community (DATAcc; hosted by the DiME Society) to help establish best practices for designing and deploying digital health measures. Ernesto has tracked over 39 million steps since 2011.

Mike is Chief Innovation officer at Fogarty Innovation. Mike has more than 35 years of industry experience spanning a broad range of positions in general management, product development, operations, sales, and marketing, clinical, regulatory, and engineering. He most recently served as chief operating officer at Minerva Surgical, a medical technology company focused on women’s healthcare. Prior to that, he was vice president of operations at Emphasys Medical (now Pulmonx), a company that develops therapeutic solutions for patients with emphysema. He was also chief operating officer of Cardeon, which focused on innovative approaches for cardiac surgery, and worked in interventional cardiology and cardiac rhythm management at Guidant, after his previous company, Advanced Cardiovascular Systems, was purchased. Mike holds a BS in industrial engineering from Cal Poly, San Luis Obispo, and an MBA from Santa Clara University.

Joseph Rock is a Senior Scientist in Philips’ Research. Mr. Rock started his career at Hewlett-Packard Medical Products Group, then moved to Philips as part of their acquisition of Agilent Technologies. He has spent more than 32 years in the medical device and informatics industries. Mr. Rock has been issued a number of U.S. and worldwide patents and had his work published in peer-reviewed journals and presented at major cardiology conferences. His primary interests are in clinical decision support and big data analytics. Joe holds a B.S. in Computer Science with interests in Biomedical Engineering from Worcester Polytechnic Institute and an M.S. in Healthcare Informatics from the University of Massachusetts - Lowell.

Sean Saint was the co-founder and CEO of Companion Medical, Inc. from its inception in 2013 through acquisition by Medtronic in 2020. Companion Medical launched the first FDA cleared Smart Insulin Pen. The InPen device was designed to provide many of the benefits of Insulin pumps to the 93% of people who do not use pumps. Like his other roles, Sean focused on bringing solutions to problems people with diabetes faced in order to reduce the burden of living with diabetes. Prior to founding Companion Medical in 2013, Sean worked in roles of increasing responsibility at Tandem Diabetes Care, Alure Medical, Dexcom, and Medtronic/AVE. Sean holds a Bachelor of Science in Mechanical Engineering from California Polytechnic State University – San Luis Obispo and is a registered Professional Engineer in the state of California. He has over 175 issued and pending patent applications. Beyond his professional resume, Sean was diagnosed with type 1 diabetes as an adult and uses InPen™ today to manage his diabetes. He is well-known in the diabetes community.

Enrico Santus is a senior data scientist at Bayer. After obtaining his PhD at the Chinese and Bilingual Studies department of The Hong Kong Polytechnic University, he worked in several academic institutions, including CSAIL (MIT), in the group of Regina Barzilay. Enrico has published over 50 papers on topics related to the application of Artificial Intelligence to Precision Medicine, Epidemiology, Oncology and Cardiology. His work includes research on natural language processing approaches for the automatic fake news detection and sentiment analysis. Enrico collaborated to the creation of The Prayer (artist: Diemut Strebe), a mouth-shaped robot which produces original prayers and that was exposed at the Centre Pompidou of Paris. He is the first author of a fact sheet about Artificial Intelligence for the American Congress (https://www.belfercenter.org/publication/technology-factsheet-artificial-intelligence) and, in 2019, he was invited speaker at the Record Management Office of the White House. Claim to fame: From art to science, from politics to healthcare, Enrico has shown how natural language processing and machine learning will be impacting our lives in the years to come.

Disha Sheth, PhD, is a Sr. Staff Scientist at Dexcom Inc., a leader in the continuous glucose monitoring industry. She managed a team of scientists and engineers and guides projects to make continuous improvements in the CGM technology, to give diabetes patients the best experience possible in management their disease. She was a postdoctoral fellow at FDA where she worked on the interference testing for CGMs. Prior to that she obtained her PhD from Case Western Reserve University and MS from Columbia University in Biomedical Engineering studying biosensors.

Dr. Stacey Standridge is Deputy Director of the National Nanotechnology Coordination Office (NNCO) and also serves as the Coordinator for Global Issues for the National Nanotechnology Initiative (NNI), a Federal R&D initiative involving 20 departments and independent agencies. She joined the NNCO in 2011 as a AAAS Science & Technology Policy Fellow and served in roles of increased responsibility before becoming Deputy Director in July 2018. Dr. Standridge has managed high-profile projects such as the development of the 2014 and 2016 NNI Strategic Plans, and leads interagency cooperation in focused areas of national importance under the Nanotechnology Signatures Initiatives. She has played a critical role in creating and sustaining a long-term collaboration with the European Commission and European scientists on nanosafety research. Dr. Standridge earned her PhD in Chemistry at Northwestern University and a BS in Chemistry from the University of Oregon.

Ralph Stohn is VP of Research & Development at EarlySense, responsible for leading technology, algorithm, research and engineering teams. Under Ralph's leadership, EarlySense develops proprietary algorithms, passive, contact-free sensing hardware, software, AI-driven data science applications, and systems engineering for use in hospitals, facilities and homes.

Nikin is the Co-Founder and CEO of Medsix, a medical device startup based in Boston focused on improving post-operative recovery management for patients managed with wound drains. Prior to Medsix, Nikin was the founding engineer at a deep-tech startup developing novel radiation detectors. He has a background in electronics and has been the recipient of several awards including BostInno's Top 25 Under 25, Forbes U30 Scholar and Young Global Shaper at the World Economic Forum.

Long history in modelling, software/firmware/hardware development for semiconductors, flight control, communication, and storage industries. Many of my products are in mass production.

Joseph Wang studied chemistry at the Technion and was awarded the BSc degree in 1972 and an MSc degree in 1974. After completing his D.Sc. at the Technion in 1978, he served as a postdoctoral research associate at the University of Wisconsin, Madison. In 1980, he joined the Department of Chemistry and Biochemistry at New Mexico State University, where he became a Regents Professor and holder of the Manasse Chair. Wang founded the journal Electroanalysis (Wiley-VCH) in 1988 and was Editor-in-Chief for three decades until 2018.[3] From 2004 to 2008, he served as the Director of the Center for Bioelectronics and Biosensors at the Biodesign Institute and as a Professor of Chemical Engineering and Chemistry at Arizona State University (ASU). Since 2008, Wang has served as Distinguished Professor of Nanoengineering at the University of California, San Diego, and as Department Chair between 2014 and 2019.

Craig currently serves as the General Manager of Cambridge EnerTech with primary responsibilities for scientific conference organization and program development within energy market sectors with conferences based in the United States, Asia, Australia and Europe. Prior to that and since 2014, Craig served as Executive Director of Conferences for Cambridge Enertech. Previously to joining CII and forming Cambridge EnerTech, Craig was the Founder and President of the Knowledge Foundation, a scientific conference and publishing company until it was acquired by CII in 2014. Additionally, Craig was a Director at IBC USA (now Informa), and has previous experience in conference development, publishing and technical marketing.

Over 30 years of experience in healthcare, medical device, and diagnostics industry with extensive experiences in chemical sensors and biosensors, and with leadership and R&D management; 20 years in diabetes care industry for BGM product development and BGM/cgm algorithm development. Major contributions to algorithm with formulation leading to Contour NEXT family meters with accuracy of ±10% and Contour NEXT One family meters with accuracy of ±8.5%. Holds USPTO patent agent license, with 90 US patents and 100+ international patents.